Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
SAN MATEO, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced it has raised over $31 million in a Series F financing to accelerate the commercial adoption of a neurovascular intervention portfolio focused on acute ischemic […]
View More
Route 92 Medical’s Monopoint® Operating Platform Shows 82% First Pass Effect in Independent Study
View More
Route 92 Medical® Announces Publication of Initial SUMMIT NZ Clinical Trial Results Demonstrating 80% First Pass Effect with the 088 Monopoint® Operating Platform
View More
Route 92 Medical® Announces Receipt of 40th Patent for its Monopoint® Operating Platform Designed for Neurovascular Intervention
View More